In fact, in AD brain, PPARγ agonists can directly improve the processing of the Aβ peptide by regulating insulin degrading enzyme (IDE), but can also regulate the inflammatory status and the mitochondrial function by modulating oxidative stress. Here, IDE is linked to Alzheimer disease.